Article
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
9 Jan 2024
Abstract excerpt
Tuberous Sclerosis Complex (TSC) is caused by TSC1 or TSC2 mutations, leading to hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and lesions in multiple organs including lung (lymphangioleiomyomatosis) and kidney (angiomyolipoma and renal cell carcinoma). Previously, we found that TFEB is constitutively active in TSC. Here, we generated two mouse models of TSC in which kidney pathology is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
